Skip to main content

Day: February 26, 2026

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day hospital discharge Four systemic sclerosis patients and the first idiopathic inflammatory myopathy patient treated with FT819; First systemic sclerosis patient reaching 3-month evaluation timepoint shows meaningful disease improvement using less-intensive conditioning chemotherapy FT819 Phase 1 enrollment expanded across 16 clinical sites in the U.S., U.K. and EU, with 15 systemic lupus erythematosus patients enrolled to date, supported by increased interest in FT819 safety, efficacy and on-demand accessibility profile Colorectal cancer patient shows greater than 50% reduction in CEA levels with tumor reduction across all target lesions after treatment with FT836, a MICA/B-targeted off-the-shelf...

Continue reading

Stolt-Nielsen Limited Board Recommends Final Dividend for 2025 of $1 per Common Share

LONDON, February 26, 2026 – Stolt-Nielsen Limited (Oslo Børs: SNI) announced today that the Company’s Board of Directors recommended a final dividend for 2025 of $1.00 per Common Share, payable on May 6, 2026 to shareholders of record as of April 22, 2026. The shares will trade ex-dividend on and after April 21, 2026. The dividend, which is subject to shareholder approval, will be voted on at the Company’s Annual General Meeting of Shareholders scheduled for April 16, 2026 in Bermuda. If approved, this will bring the full dividend for 2025 to $2.00 per Common Share. For additional information please contact:  Jens F. Grüner-HeggeChief Financial OfficerUK +44 (0) 20 7611 8985j.gruner-hegge@stolt.com About Stolt-Nielsen LimitedStolt-Nielsen (SNL or the ‘Company’) is a long-term investor and manager of businesses focused on opportunities...

Continue reading

Changes in the Management Board of AS Tallink Grupp

AS Tallink Grupp (the “Group”) has elected Peep Jalakas as the new Chairman of the Management Board. The term of office of Mr. Jalakas will commence on 6 April 2026 and will last for three years. In addition, the Supervisory Board has resolved to recall Margus Schults from the Management Board with effect from 27 February 2026. He will continue in his role as Managing Director of Tallink Silja Oy. Peep Jalakas joined SEB Bank in 2006 and has held several senior management positions since 2010, including serving as Head of Corporate Banking and Head of Credit. Since 2023, he has been a Member of the Management Board of SEB Bank and Head of Corporate Banking. Peep Jalakas and persons closely associated with him do not hold any shares in the Group. “Tallink Grupp is a strong and sustainable international company with a solid market position...

Continue reading

Changes in the Management Board of AS Tallink Grupp

AS Tallink Grupp (the “Group”) has elected Peep Jalakas as the new Chairman of the Management Board. The term of office of Mr. Jalakas will commence on 6 April 2026 and will last for three years. In addition, the Supervisory Board has resolved to recall Margus Schults from the Management Board with effect from 27 February 2026. He will continue in his role as Managing Director of Tallink Silja Oy. Peep Jalakas joined SEB Bank in 2006 and has held several senior management positions since 2010, including serving as Head of Corporate Banking and Head of Credit. Since 2023, he has been a Member of the Management Board of SEB Bank and Head of Corporate Banking. Peep Jalakas and persons closely associated with him do not hold any shares in the Group. “Tallink Grupp is a strong and sustainable international company with a solid market position...

Continue reading

AB KN Energies unaudited financial information for the twelve months of 2025

AB KN Energies (hereinafter – KNE, the Company) announces the unaudited consolidated (hereinafter – the Group) and separate financial results for the twelve months ended 31 December 2025. Key financial indicators for the 1-12 months of 2025:EUR millions Group Company  1-12 months of 2025 1-12 months of 2024 1-12 months of 2025 1-12 months of 2024Revenue 105.2 93.7 99.9 89.4EBITDA 53.5 48.8 51.2 46.4Net profit (loss) 18.2 15.4 16.7 13.8Management comment: Consistent execution of Group’s long-term strategy, expansion of international LNG activities and operational efficiency initiatives drove stronger Group results in 2025. Compared with 2024, Group revenue grew by 12% to EUR 105.2 million, EBITDA increased by 10% to EUR 53.5 million, and net profit rose by 19% to EUR 18.2 million (according to unaudited data). Liquid...

Continue reading

Form 8.3 – Augmentum Fintech Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Augmentum Fintech Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Lakeland Fire + Safety’s California PPE Opens Second California Facility in Fresno to Provide Service and Training to Fire Departments

Offers State-of-the-Art Technology Extractors and Systems for Advanced Care and Maintenance of Firefighting Equipment, and NFPA 1850 Classes Grand Opening and NFPA 1850 Class to be Held March 3rd to 4th HUNTSVILLE, Ala., Feb. 26, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced its California PPE Recon, Inc. (“California PPE”) subsidiary, which specializes in personal protective equipment (PPE) care and maintenance services, will host a grand opening of “California PPE, Fresno”, a new state-of-the-art facility providing compliant decontamination, inspection and repair services to California Fire Departments and National Fire...

Continue reading

Playboy Appoints David Miller as President, Media & Brand

Media Veteran Miller to Oversee Global Licensing, Digital and Platform Growth Senior Appointment Reflects Playboy’s Accelerating Growth Strategy and Expanding Media and Licensing Operations LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) — Playboy, Inc. (Nasdaq: PLBY) (“Playboy” or the “Company”), a global pleasure and leisure company, has announced that David Miller has been appointed President, Media & Brand, to drive the next phase of the Company’s growth. Miller joins Playboy from The Walt Disney Company, where he served as Executive Vice President and General Manager of National Geographic Media, with full P&L responsibility across global editorial, digital, print, and social operations. During his tenure, National Geographic became the most-followed brand on social media worldwide, reaching more than 800 million followers...

Continue reading

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment in March 2026 with topline data expected in Q4 2026 Initial data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF) presented at the American Society of Hematology (ASH) conference demonstrating meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status or concomitant JAK inhibitor therapy use Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera (PV) and initiated a Phase 1b study of DISC-3405 in sickle cell disease (SCD) in Q4 2025, with data from both studies expected in 2H 2026 Strong financial position ending Q4 with approximately $791 million in cash, cash equivalents, and marketable securities,...

Continue reading

Where Food Comes From, Inc. Reports 2025 Financial Results

Full Year Highlights – 2025 vs. 2024Verification and certification revenue: $20.1M vs. $20.6MProduct sales: $3.6M vs. $3.8MTotal revenue: $24.9M vs. $25.7MNet income: $1.5M vs. $2.1MDiluted EPS: $0.30 vs. $0.40Cash generated from operations: $1.6M vs. $2.7MCash & cash equivalents: $3.2M vs. $2.0M at 2024 year-endStock buybacks: 183,016 sharesTotal buybacks since plan inception (including private purchases): 1,374,652 shares at purchase price of approximately $15.2 millionFourth Quarter Highlights – 2025 vs. 2024Verification and certification revenue: $5.0M vs. $5.4MProduct sales: $0.7M vs. $0.9MTotal revenue: $6.0M vs. $6.7MNet loss of $0.2M vs. net income of $1.0MDiluted EPS: ($0.04) vs. $0.18Stock buybacks: 66,469 sharesCASTLE ROCK, Colo., Feb. 26, 2026 (GLOBE NEWSWIRE) — Where Food Comes...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.